BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
411.29
-5.25 (-1.26%)
Nov 16, 2026, 4:00 PM EST - Market closed

BeOne Medicines AG Revenue

BeOne Medicines AG had revenue of 1.89B CNY in the quarter ending September 30, 2026, with 33.81% growth. This brings the company's total for the last twelve months to 6.61B, up 32.86% year-over-year. In the year 2025, BeOne Medicines AG had annual revenue of 5.34B with 40.23% growth.

Revenue (ttm)
6.61B CNY
Revenue Growth
+32.86%
P/S Ratio
7.29
Revenue / Employee
550,541 CNY
Employees
12,000
Market Cap
46.98B USD

Revenue Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart
  • BRUKINSA 3.93B 74.7%
  • TEVIMBRA 737.30M 14.0%
  • XGEVA 305.98M 5.8%
  • BLINCYTO 104.22M 2.0%
  • KYPROLIS 74.97M 1.4%
  • Collaboration 60.97M 1.2%
  • POBEVCY 47.40M 0.9%

By Geography

Chart
  • U.S. 2.88B 53.9%
  • China 1.68B 31.4%
  • Europe 611.37M 11.4%
  • Rest of World 171.81M 3.2%
Fiscal year ended Dec 31, 2025 See the full BeOne Medicines AG breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.34B1.53B40.23%
Dec 31, 20243.81B1.35B54.96%
Dec 31, 20232.46B1.04B73.65%
Dec 31, 20221.42B239.64M20.37%
Dec 31, 20211.18B867.41M280.83%
Dec 31, 2020308.87M-119.34M-27.87%
Dec 31, 2019428.21M229.99M116.03%
Dec 31, 2018198.22M173.79M711.45%
Dec 31, 201724.43M--
Dec 31, 2016---
Dec 31, 20158.82M-4.22M-32.37%
Dec 31, 201413.04M1.89M16.93%
Dec 31, 201311.15M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.